Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
03/2001
03/21/2001CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound
03/21/2001CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof
03/20/2001US6204294 IL-8 receptor antagonists
03/15/2001WO2001017977A1 1,3,5-triazines as herbicides
03/15/2001WO2001017948A1 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1083166A1 Novel substituted guanidine derivatives and process for producing the same
03/14/2001CN1287118A Method of preparing creatine or its hydrate
03/08/2001WO2000072800A3 Il-8 receptor antagonists
03/07/2001CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them
03/07/2001CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines
03/06/2001US6197214 Ammonium thiosulfate complex of gold or silver and an amine
03/01/2001WO2001014324A1 Selective inhibitors of the urokinase plasminogene activators
03/01/2001WO2001014323A1 Method for producing 1-methyl-3-nitroguanidine
03/01/2001DE19940389A1 Selektive Inhibitoren des Urokinase-Plasminogen Aktivators Selective inhibitors of urokinase plasminogen activator
02/2001
02/28/2001EP1077933A1 Substituted guanidines and diaminonitroethenes, their preparation and use
02/28/2001CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same
02/28/2001CN1062554C Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound
02/27/2001US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents
02/27/2001US6194446 Hypoglycemic and hypolipidemic compounds
02/27/2001US6194380 Agents for promoting bone formation
02/27/2001CA2185165C Process for the synthesis of cationic surfactants derived from the condensation of fatty acids with esterified basic-character amino acids and their application as antimicrobial agents
02/27/2001CA2101316C Gnrh analogs
02/22/2001WO2001012634A1 Group(iii)-metal-hydrides with a guanidino-type ligand
02/22/2001DE19939609A1 Pure 1-methyl-3-nitroguanidine preparation in high yield for use as insecticide intermediate, by reacting cyanogen halide with methylamine then ammonium nitrate and dehydrating product
02/21/2001EP1076643A1 Biphenyl derivatives
02/21/2001CN1284950A Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
02/15/2001WO2001010849A2 Substituted arylalkylamino-1,3,5-triazines as herbicides
02/15/2001WO2001010841A2 Fluorene derivatives as integrin inhibitors
02/15/2001WO2001010835A1 Antibacterial agents
02/15/2001DE19936633A1 Substituierte Arylalkylamino-1,3,5-triazine Substituted arylalkylamino-1,3,5-triazines
02/15/2001CA2380981A1 Fluorene derivatives
02/14/2001EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
02/14/2001CN1284069A Substituted 2,4-diamino-1,3,5-triazines
02/14/2001CN1284060A Novel metalloproteinase inhibitors
02/14/2001CN1284058A Neuroprotective agents
02/14/2001CN1283447A Locally-used weight reducing face-care compsns.
02/14/2001CN1061974C Process for synthesis of guanidine dihydrogen phosphate and guanidine hydrogen phosphate
02/13/2001US6187955 Guanidine derivatives and process for their production
02/08/2001WO2001009096A2 Potassium channel openers
02/08/2001DE19937394A1 Fluorenderivate Fluoro derivatives
02/08/2001CA2378936A1 Potassium channel openers
02/07/2001EP1073650A1 Guanidine derivatives
02/07/2001EP1073623A1 Substituted amino acids as erythropoietin mimetics
02/07/2001EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
02/07/2001CN1061648C Antiarrhythmic and cardioprotective substituted indenoyiguanidines
02/07/2001CN1061647C Process for preparing creatine or creatine hydrate
02/01/2001WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis
01/2001
01/31/2001CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors
01/30/2001US6180140 Modified amino acids for drug delivery
01/25/2001WO2001005753A1 Diacylhydrazine derivatives
01/25/2001WO2001005752A1 Aminoguanidine bicarbonate with particular properties and method for making same
01/25/2001CA2379041A1 Diacylhydrazine derivatives
01/24/2001EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
01/24/2001EP1070046A1 Propanolamine derivatives
01/18/2001WO2001004128A1 Bioavailable chelates of creatine and essential metals
01/18/2001DE19932796A1 Diacylhydrazinderivate Diacylhydrazinderivate
01/17/2001EP1068178A1 NON-PEPTIDE GnRH AGENTS
01/17/2001CN1060764C Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing them
01/17/2001CN1060763C Urea-substituted benzoylguanidines, process for their preparation, and use and pharmaceutical containing them
01/16/2001US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound
01/16/2001US6174887 Amide compounds and use of the same
01/11/2001DE19929993A1 New creatine alpha-ketoglutarate compounds, having synergistic activity e.g. in improving sporting strength and endurance, eliminating blood ammonia or treating liver diseases
01/10/2001CN1279666A NPY antagonists
01/09/2001US6172111 Salt formation; antiobesity and strengthening agents
01/09/2001CA2117483C [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
01/04/2001WO2001000623A1 Method of producing nitroguanidine- and nitroenamine derivatives
01/04/2001WO2001000571A1 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
01/04/2001WO2001000558A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
01/04/2001WO2001000206A1 Vla-4 inhibitor compounds
01/04/2001WO2000035868A3 Methods for the synthesis of alpha-hydroxy-beta-amino acid and amide derivatives
01/04/2001CA2377287A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
01/04/2001CA2377240A1 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
01/04/2001CA2369308A1 Vla-4 inhibitor compounds
01/03/2001CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
12/2000
12/28/2000WO2000078737A2 Aryloxy ethylamino triazines as herbicides
12/27/2000EP1062264A2 Enzyme inhibitors
12/27/2000EP1021099A4 Anti-bacterial amine derivatives
12/26/2000US6166249 Creatine pyruvates
12/26/2000US6166239 Useful during oligonucleotide synthesis to protect nucleobase amines as well as tethered amines used for attaching functional moieties to oligonucleotides.
12/21/2000WO2000076991A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
12/21/2000WO2000076517A1 Il-8 receptor antagonists
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000DE19927611A1 New aryloxyethylamino-triazine derivatives are used as herbicides, especially for selective control of undesired plant growth in cotton, barley, maize, beet and wheat
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2374627A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
12/20/2000EP1060739A1 Slimming cosmetic composition containing L-arginine or a derivative thereof
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/14/2000WO2000046187A3 Antizyme modulators and their use
12/12/2000US6160134 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
12/07/2000WO2000073258A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072800A2 Il-8 receptor antagonists
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/06/2000EP0775692B1 Guanidinomethyl cyclohexane carboxylic ester derivative
12/05/2000US6156741 Nervous system disorders
12/05/2000US6156735 Arginine silicate inositol complex and use thereof
12/05/2000CA2188452C Guanidino-substituted compounds
11/2000
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 54